-
August 24, 2022 Psilocybin Reduces Heavy Drinking in Patients with Alcohol Use DisorderA new study indicates that psilocybin-assisted therapy may reduce heavy drinking in patients with alcohol...
-
August 24, 2022 Can an Ayahuasca Ceremony Heal Immigrant and Refugee Trauma?A unique study looks at how an ayahuasca ceremony may help rebuild community and heal...
-
August 11, 2022 An Inside Look into Field Trip’s Next-Generation Psychedelic, FT-104Field Trip is the only company exploring the therapeutic potential of a 4-HO-DiPT prodrug called...
-
August 10, 2022 Compass Pathways Sued for Stealing Trade SecretsCompass Pathways faces a legal challenge from Terran Biosciences over the potential theft of intellectual...
-
August 9, 2022 Psychedelic Clinical Trials and the Michael Pollan EffectWith the incredible popularity of “How to Change Your Mind,” Michael Pollan sells people on...
-
August 8, 2022 Three Phase 3 Clinical Trials that Could Legalize PsychedelicsThe road to psychedelic legalization has many paths. These 3 clinical trials have the best...
-
July 29, 2022 The Real Reason Cybin Bought Entheon’s DMT Clinical TrialIn a rare move Cybin aquires a phase 1 DMT clinical trial from Entheon Biomedical....
-
July 29, 2022 The Truth about Depression: Serotonin, SSRIs and PsychedelicsA new review finds that the chemical imbalance model of depression is wrong. What lessons...
-
July 28, 2022 Project Solace: The World’s Largest Medical Psilocybin Access and Data ProjectProject Solace uses real-world data to inform development of regulated psilocybin therapy, led by Canadian...
-
July 27, 2022 3 Microdosing Clinical Trials to Keep an Eye OnDoes microdosing psychedelics work, or is it the placebo effect? Here are 3 microdosing clinical...
